Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Mouse anti-Human IgA1 Antibody (PE)

ELISA Monoclonal B3506B4 IgG1 PE
Catalog No. ABIN376571
  • Target See all IgA1 products
    IgA1
    Reactivity
    Human
    Host
    • 7
    • 2
    • 2
    Mouse
    Clonality
    • 9
    • 2
    Monoclonal
    Conjugate
    • 4
    • 3
    • 2
    • 1
    • 1
    PE
    Application
    • 7
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    ELISA
    Specificity
    Human IgA1 Fc, Mr 170 kDa
    Characteristics
    Mouse Anti-Human IgA1-PE
    Purification
    Purified
    Immunogen
    Fc fragment of human IgA1 myeloma protein
    Clone
    B3506B4
    Isotype
    IgG1
  • Application Notes
    • Applications: ELISA - Quality tested , FLISA - Quality tested ELISPOT - Reported in literature , FC - Reported in literature , IHC-FS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , Multiplex - Reported in literature , Sep - Reported in literature , Depletion - Reported in literature
    • Working Dilutions: ELISA AP conjugate 1:1,000 - 1:4,000 HRP conjugate 1:1,000 - 1:4,000 BIOT conjugate 1:5,000 - 1:10,000 FLISA FITC and AF488 conjugates 1:200 - 1:400 PE and AF647 conjugates ≤ 1 g/mL
    Restrictions
    For Research Use only
  • Concentration
    0.1 mg/mL
    Buffer
    0.1 mg in 1.0 mL of PBS/Sodium azide and a stabilizing agent
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handling Advice
    Do not freeze!
    Protect conjugated products from light.

    Each reagent is stable for the period shown on the bottle label if stored as directed.
    Storage
    4 °C
    Storage Comment
    Store at 2-8°C
  • Violari, Cotton, Kuhn, Schramm, Paximadis, Loubser, Shalekoff, Da Costa Dias, Otwombe, Liberty, McIntyre, Babiker, Gibb, Tiemessen: "A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation." in: Nature communications, Vol. 10, Issue 1, pp. 412, (2019) (PubMed).

  • Target
    IgA1
    Abstract
    IgA1 Products
You are here:
Support